Results 121 to 130 of about 67,420 (308)

Variable Length Space Time Coded Modulation [PDF]

open access: yes, 2005
A Variable Length Space Time Coded Modulation (VL-STCM) scheme capable of simultaneously providing coding, multiplexing and diversity gains is proposed.
Ng, S.X.   +3 more
core  

Soft-Bit Assisted Iterative AMR-WB Source-Decoding and Turbo-Detection of Channel-Coded Differential Space-Time Spreading Using Sphere Packing Modulation [PDF]

open access: yes, 2007
Jointly optimised iterative source- and channel-decoding is used for enhancing the error resilience of the Adaptive Multi Rate WideBand (AMR-WB) speech codec.
Alamri, O.   +8 more
core   +1 more source

Design of Mapping Matrix for Arithmetic Bit-Interleaved Coded Modulation

open access: yesIEEE Access, 2019
Arithmetic bit-interleaved coded modulation (A-BICM) is a coded rate compatible modulation (RCM). It achieves progressive mapping to strike a trade-off between high signal-to-noise ratio (SNR) and low SNR.
Jinkun Zhu   +4 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Fundamental performance limits of CPM coded modulation system

open access: yesTongxin xuebao, 2014
The study of the capacity of CPM systems was concerned with.The definition as well as the Finite-State-Machine (FSM) model of CPM was introduced.The development of calculating the capacity of CPM over AWGN channels was first reviewed.Then this ...
Bing LI, Fan WEI, Bao-ming BAI, Xiao MA
doaj   +2 more sources

Tumor B‐cell infiltration in platinum‐treated advanced muscle‐invasive urothelial carcinoma

open access: yesMolecular Oncology, EarlyView.
Bladder tumors with higher pretreatment memory B‐cell infiltration were linked to longer survival after cisplatin chemotherapy, but not carboplatin. These tumors also showed more organized immune structures (tertiary lymphoid structures) and a shared pro‐inflammatory B‐cell‐rich community, suggesting that memory B cells may help identify patients most ...
Konrad Stawiski   +10 more
wiley   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

open access: yesMolecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola   +11 more
wiley   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Jointly optimised iterative source-coding, channel-coding and modulation for transmission over wireless channels [PDF]

open access: yes, 2004
Joint source-coding, channel-coding and modulation schemes based on Variable Length Codes (VLCs), Trellis Coded Modulation (TCM), Turbo TCM (TTCM), Bit-Interleaved Coded Modulation (BICM) and iteratively decoded BICM (BICM-ID) schemes are proposed.
Yang, L.-L.   +4 more
core  

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

open access: yesMolecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy